The IQT Podcast cover image

The Intersection Podcast: Exploring the Nexus of AI & Quantum

The IQT Podcast

NOTE

Significance of Failure in Phase Three Clinical Trials

The failure rate in phase three clinical trials is high at 40%, which is categorized as the stage for scale-up involving thousands of participants. This indicates a critical point in the drug development process where a significant portion of failures occur.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner